Iron excess is associated with cardiovascular disease, joint disease, liver disease and various endocrine disorders. The assay for serum ferritin may be used to assess total body iron stores but this test lacks speci¢-city. Until recently, the most reliable method for an assessment of total body iron required a liver biopsy that was then subjected to histochemical and/or biochemical assessment. Various non-invasive imaging techniques have been tried to assay body iron because liver biopsy has an appreciable morbidity and mortality. Unfortunately, iron is not detectable with ultrasound, computerized tomography cannot reliably detect iron and magnetic resonance signals diminish as iron deposition in liver increases making this technique di¤cult to interpret. Gandon et al. have now devised a calculation algorithm (http:// www.radio.univ-rennes1.fr) that overcomes the problems associated with magnetic resonance imaging and that takes advantage of the paramagnetic properties of iron to enhance its detection.
Gandon et al. used 139 patients in a study group to create a database. These patients had a percutaneous liver biopsy followed by biochemical assessment of the iron content of the liver biopsy. An MRI scan of the liver was performed to compute liver/muscle signal intensity weighted for iron detection. Liver tissue is typically the most a¡ected by iron deposition whereas skeletal muscle is relatively spared. The results generated for the study group were compared and an algorithm was devised that would calculate the iron content of the liver from the MRI scan alone. They further studied 35 patients in a validation group. These patients had an MRI scan that computed liver iron content and this was then compared to the liver iron content reported by conventional assay of a liver biopsy. Liver iron stores could be reliably detected at concentrations 460 mmol/g of tissue (reference interval 535 mmol/g of tissue). The MRI scan is non-invasive, takes about 15 min to perform and does not require preoperative echographic assessment or admission to hospital. An MRI scan can analyse large volumes of liver and so avoids problems associated with liver biopsies of disease states such as cirrhosis where iron deposition may be non-homogeneous.
This report has shown that the future of MRI may lie in functional imaging. Where now, basic biochemistry?
JD Johnston
Queen Elizabeth Hospital, London, UK A new in vitro blood load test using a magnesium stable isotope for assessment of magnesium status Markers of magnesium status include measurements of the total or ionized concentrations in serum and blood cells, and in muscle tissue using in vivo techniques. However, all have some limitations to their usefulness. Using radioactive 28 Mg it has been seen that Mg-de¢cient rats show increased uptake into tissues following i.p. administration of the isotope, presumably due to increased cellular demand for magnesium. To further investigate this hypothesis and to determine whether the observations might be used to assess magnesium status in humans these authors developed a blood load test using a stable isotope.
Blood was collected from rats with either adequate or de¢cient magnesium diets. Blood samples were also collected from10 healthy adult human volunteers. The fresh blood was incubated with 25 Mg at 378C for 2 h and then the erythrocytes, lymphocytes and platelets were isolated for measurement of total Mg, 25 Mg and 26 Mg. 25 Mg enrichment was calculated as the relative enrichment (  25 Mg: 26 Mg ratio as a percentage of the ratio in non-enriched blood) and as the net enrichment (mmol/10 12 cells). Concentrations of total and free magnesium were signi¢cantly reduced in the plasma of the Mg-de¢cient rats compared with their controls, as was the total magnesium in erythrocytes. However, in the lymphocytes and platelets there were no di¡erences between the two groups. The measures of 25 Mg enrichment were signi¢cantly increased in all cell types with the greatest change seen for the relative enrichment in erythrocytes, 122+/729% compared with 38+/72% in the non-depleted animals. In the human study the plasma total and free magnesium and the erythrocyte magnesium concentrations were normal. When compared against the enrichment determined in the control rats, results for human erythrocytes were much lower (2.8+/71.2%). However the data were similar for lymphocytes and platelets.
To explain the contradiction between the normal total magnesium concentration with enhanced enrichment, seen in the lymphocytes and platelets of the de¢cient rats, the authors suggest a protective mechanism to maintain the intracellular concentration but that the cellular £ux of Mg 2+ is perturbed. The low enrichment in human erythrocytes could be due to a low permeability of the human red cell membrane compared with that of the rat, a feature that has been previously reported. However, useful enrichment was seen with lymphocytes and platelets suggesting that these cells would be more appropriate in an in vitro loading test for human magnesium de¢ciency. More studies are required to see if this test is a useful marker of human magnesium de¢ciencyand the work involved in harvesting cells from fresh blood is such that it is unlikely to become a widely used investigation. Carbohydrate metabolism is very often one of, if not the ¢rst topic, encountered in undergraduate biochemistry courses. It is therefore not surprising that inherited disorders of carbohydrate metabolism have a virtual universal appeal. A classic feature of McArdle's disease is severe cardiopulmonary distress and muscle cramp at the beginning of exercise followed by a second wind phenomenon when the subject can continue to exercise with the same or greater power demands. The exhaustion those a¡ected experience within 5 min of relatively trivial exercise, although subject to marked intra-individual variation, can be very restrictive and is the major symptom of the condition issue addressed by Vissing and Haller. The report is very unsatisfactory for a number of reasons. It is long established that the ingestion of food and in particular carbohydrates such as glucose and fructose ameliorate and can prevent the development of these symptoms. Thus to hail oral sucrose as Sweet success^a treatment for McArdle's disease as the accompanying Perspective in the journal proclaimed is not justi¢ed. The power demands of the exercise performed by the subjects was 50 watts^equivalent to a very leisurely stroll at approximately 2 mph along a canal bank with no wind^is what one would expect of patients with grade 3 if not 4 NYHA heart failure. The amount of sucrose recommended, 75 g (the amount contained in two 330 mL cans of popular non-diet carbonated sweet drinks), 30 min before exercise, yields 1125 MJ of metabolic energy, at the work rate achieved by the subjects, equivalent to over 6 h of exercise! Nor did they demonstrate that the sucrose would increase their work rate once over the initial period of exercise.
A Taylor
The accompanying Perspective is disappointing as it refers to the`forearm exercise test' not mentioning the ischaemic nature of the exercise. The author states that the ingestion of sucrose`reduces the risk of myoglobinuria', which the study did not address. Rather than drink the two cans, in view of current concerns about obesity, patients should be recommended to use them to help with gently exercising their forearms for 10 min before the start of exercise, which is also e¡ective. There is increasing evidence to support a bidirectional relationship between iron metabolism and type 2 diabetes. The association between haemochromatosis and type 2 diabetes has long been known but increasingly research has focused on the metabolic links between iron and glucose. Total body iron stores are positively correlated with the onset of impaired glucose tolerance and type 2 diabetes. This is of concern given the number of patients with increased body iron stores in the general population^28% elderly men and 12% elderly women in a recent US study.
Iron has many e¡ects on glucose metabolism. Serum ferritin concentrations show a positive correlation with insulin resistance and iron stores are inversely correlated with HDL cholesterol. Glucose metabolism is linked with iron in several metabolic pathways; for example insulin increases iron uptake by fat cells and increases the number of transferrin receptors at the cell surface. Iron is a potent prooxidant and is linked to oxidative stress^a process which leads to increased ferritin synthesis and insulin resistance. In£ammatory cytokines have the potential to a¡ect these processes and potentially amplify their e¡ects.
There are a number of studies that have examined the possible therapeutic e¡ects of iron depletion on the risks of developing type 2 diabetes or insulin resistance. Both therapeutic venesection and iron chelation with subcutaneous deferrioxamine have been shown to improve glycaemic control in patients with haemochromatosis. In addition, regular phlebotomy reduced insulin requirements in patients with type 2 diabetes.
The tissue damage mediated by iron may be a factor in the development of chronic macrovascular complications of diabetes and strategies to reduce iron stores may have bene¢cial e¡ects on the atherosclerotic process.
